Tildrakizumab for the treatment of plaque psoriasis in adults
Sign Up to like & getrecommendations! Published in 2019 at "Prescriber"
DOI: 10.1002/psb.1771
Abstract: Tildrakizumab (Ilumetri) is a new biological therapy targeting interleukin (IL)‐23 for the treatment of plaque psoriasis in adults. This article discusses its place in therapy and clinical trial efficacy. read more here.
Keywords: plaque psoriasis; psoriasis adults; treatment plaque;